TRDA: Upcoming clinical data and platform safety position the company for accelerated approval and market growth
The EEV platform enables superior delivery and safety for oligonucleotide therapies, with clinical programs in DMD showing early functional benefits and strong safety. Upcoming data from higher-dose cohorts and expansion studies aim to confirm dose-dependent efficacy and support accelerated approva…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.